Evidence map›Paper›PMID 26001387›Full record

Trial reportBrain : a journal of neurology2015

Improving response inhibition systems in frontotemporal dementia with citalopram.

Laura E Hughes, Timothy Rittman, Ralf Regenthal, Trevor W Robbins, James B Rowe

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Brain : a journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Psychotherapy and inhibitory control: Insights from fMRI research.Psychiatry and clinical neurosciences · 2026
    Pooled it
  2. Trial
  3. Review
  4. Depression and apathy in frontotemporal dementia: a short assessment of facts and outlook.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Prefrontal Cortical Connectivity Mediates Locus Coeruleus Noradrenergic Regulation of Inhibitory Control in Older Adults.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  18. Review
  19. The Role of Oxytocin in Social Circuits and Social Behavior in Dementia.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

  • Commented on by
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Laura E Hughes1 Department of Clinical Neurosciences, University of Cambridge, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK laura.hughes@mrc-cbu.cam.ac.uk.
Timothy Rittman1 Department of Clinical Neurosciences, University of Cambridge, UK.
Ralf Regenthal3 Division of Clinical Pharmacology, Department of Pharmacology and Toxicology, University of Leipzig, Germany.
Trevor W Robbins4 Department of Psychology, University of Cambridge, Cambridge, UK 5 Behavioural and Clinical Neuroscience Institute, Cambridge, UK.
James B Rowe1 Department of Clinical Neurosciences, University of Cambridge, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK 5 Behavioural and Clinical Neuroscience Institute, Cambridge, UK.
University of Cambridge · GBLeipzig University · DE

Funding

Medical Research Council G0001354Medical Research Council G1100464Medical Research Council MC_U105597119Medical Research Council MC US A060 0016Medical Research Council MR/M009041/1Medical Research Council MR/M024873/1Medical Research Council RG62761Wellcome Trust 088324Wellcome Trust 093875Wellcome Trust 103838
6 · The paper itself

Abstract

Disinhibition is a cardinal feature of the behavioural variant of frontotemporal dementia, presenting as impulsive and impetuous behaviours that are often difficult to manage. The options for symptomatic treatments are limited, but a potential target for therapy is the restoration of serotonergic function, which is both deficient in behavioural variant frontotemporal dementia and closely associated with inhibitory control. Based on preclinical studies and psychopharmacological interventions in other disorders, we predicted that inhibition would be associated with the right inferior frontal gyrus and dependent on serotonin. Using magnetoencephalography and electroencephalography of a Go-NoGo paradigm, we investigated the neural basis of behavioural disinhibition in behavioural variant frontotemporal dementia and the effect of selective serotonin reuptake inhibition on the neural systems for response inhibition. In a randomized double-blinded placebo-controlled crossover design study, 12 patients received either a single 30 mg dose of citalopram or placebo. Twenty age-matched healthy controls underwent the same magnetoencephalography/electroencephalography protocol on one session without citalopram, providing normative data for this task. In the control group, successful NoGo trials evoked two established indices of successful response inhibition: the NoGo-N2 and NoGo-P3. Both of these components were significantly attenuated by behavioural variant frontotemporal dementia. Cortical sources associated with successful inhibition in control subjects were identified in the right inferior frontal gyrus and anterior temporal lobe, which have been strongly associated with behavioural inhibition in imaging and lesion studies. These sources were impaired by behavioural variant frontotemporal dementia. Critically, citalopram enhanced the NoGo-P3 signal in patients, relative to placebo treatment, and increased the evoked response in the right inferior frontal gyrus. Voxel-based morphometry confirmed significant atrophy of inferior frontal gyrus, alongside insular, orbitofrontal and temporal cortex in our patient cohort. Together, these data suggest that the dysfunctional prefrontal cortical systems underlying response inhibition deficits in behavioural variant frontotemporal dementia can be partially restored by increasing serotonergic neurotransmission. The results support a translational neuroscience approach to impulsive neurological disorders and indicate the potential for symptomatic treatment of behavioural variant frontotemporal dementia including serotonergic strategies to improve disinhibition.media-1vid110.1093/brain/awv133_video_abstractawv133_video_abstract.

Indexed as

Inhibition, PsychologicalAgedCitalopramCross-Over StudiesDouble-Blind MethodElectroencephalographyFemaleFrontotemporal DementiaHumansMagnetic Resonance ImagingMagnetoencephalographyMaleMiddle AgedSelective Serotonin Reuptake InhibitorsCitalopramSelective Serotonin Reuptake Inhibitorscitalopramfrontotemporal dementiamagnetoencephalographyresponse inhibitionvoxel-based morphometry

Identifiers

PMID26001387
PMCPMC5412666
OpenAlexW1908432422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.